Is Medicus Pharma Ltd. (MDCX) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.3% / 30% | 42.9% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 3.3% / 33% | 42.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 5.7% / 33% | 73.7% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 3.3% / 33% | 42.9% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 5.7% / 33% | 73.7% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -2981.2% | |
| Return on Assets (ROA) | -204.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$10M |
| Free Cash Flow | -$10M |
| Total Debt | $322,268 |
| Debt-to-Equity | 14991.5 |
| Current Ratio | 1.0 |
| Total Assets | $6M |
Price & Trading
| Last Close | $0.47 |
| 50-Day MA | $0.98 |
| 200-Day MA | $1.98 |
| Avg Volume | 3.9M |
|
52-Week Range
$0.37
| |
About Medicus Pharma Ltd. (MDCX)
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Medicus Pharma Ltd. (MDCX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Medicus Pharma Ltd. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Medicus Pharma Ltd.'s debt ratio?
Medicus Pharma Ltd.'s debt ratio is 3.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 5.7%.
What are Medicus Pharma Ltd.'s key financial metrics?
Medicus Pharma Ltd. has a market capitalization of $13M. Return on equity stands at -2981.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.